However, a study involving long-standing, incident, and anti-TNFα-treated cohorts of rheumatoid arthritis patients, linked with the Swedish Cancer Registry, concluded that the risk of lymphoma in anti-TNFα-treated patients was not higher compared to other cohorts [56,57]. Here, TNF is linked to rheumatoid arthritis.